FDA Inspection 1223634 — Cooper Institute For Advanced Reproductive Medicine
The FDA completed an inspection of Cooper Institute For Advanced Reproductive Medicine on Nov 16, 2023 in Houston, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Houston, TX (United States)